Lv5
850 积分 2025-03-31 加入
A phase 3 study of the subcutaneous programmed cell death protein 1 inhibitor sasanlimab as single agent for patients with bacillus Calmette-Guérin, unresponsiv,e high-risk, non-muscle invasive bladder cancer: CREST Study Cohort B
2个月前
已完结
795TiP Phase III study of the programmed cell death protein 1 inhibitor PF-06801591 plus bacillus Calmette-Guérin for non-muscle invasive bladder cancer
2个月前
已完结
Large-Scale Amidations in Process Chemistry: Practical Considerations for Reagent Selection and Reaction Execution
3个月前
已完结
Advancing Scalable Chemistry toward Novel CELMoDs: Process Development for the Synthesis of CC-90009
3个月前
已完结
Development and Demonstration of a High-Volume Manufacturing Process for a Key Intermediate of Dalcetrapib: Investigations on the Alkylation of Carboxylic Acids, Esters, and Nitriles
4个月前
已完结
皖公网安备34019202002308
